Structure Therapeutics Inc.

GPCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001888886

Price chart

Open-market purchases and sales by GPCR insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 22, 20265:59 PM ETSep 21, 2026Coll Crespo BlasCHIEF MEDICAL OFFICERSSaleOrdinary Shares · Derivative−12.02K$36.1459−$434.62K1.16K–SEC10b5-1
Sep 2, 20269:18 PM ETSep 1, 2026Lin XichenCHIEF SCIENTIFIC OFFICERSSaleOrdinary Shares · Derivative−5.94K$46.9205−$278.66K0–SEC10b5-1
Aug 19, 20268:23 PM ETAug 18, 2026Lin XichenCHIEF SCIENTIFIC OFFICERSSaleOrdinary Shares · Derivative−11.82K$17.8226−$210.61K0–SEC10b5-1
Aug 5, 20264:49 PM ETAug 4, 2026Lin XichenCHIEF SCIENTIFIC OFFICERSSaleOrdinary Shares · Derivative−11.82K$16.4813−$194.76K0–SEC10b5-1
Jul 24, 20269:11 AM ETJul 22, 2026FMR LLC10% Owner, Other: See Remark 1SSaleOrdinary Shares · Derivative−52.36K$16.69−$873.82K16.09K–SEC

The largest institutional positions in GPCR at the end of Q2 2026.

Institutions holding GPCR in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC7,810,306$419.18M0.02%−593,143−7.1%Reduced
WELLINGTON MANAGEMENT GROUP LLP7,379,433$396.05M0.07%+119,146+1.6%Added
Avoro Capital Advisors LLC6,555,555$351.84M3.16%00.0%Unchanged
Jupiter Topco LLC5,204,212$279.34M0.11%+5,204,212New
Deep Track Capital, LP4,740,072$254.4M3.75%+460,224+10.8%Added